Search

everythinglearnresearchcommunity

for

Search:↓

Two mouse mutations cause similar hair loss despite different skin changes.

The congress showed that psychological therapy can help skin condition patients, social media affects acne stigma, education improves atopic dermatitis, and patient satisfaction in dermatology is high, especially with good doctor engagement.

Vitiligo is a skin condition causing white spots, more common in women, often starts before age 20, and can affect mental health.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Antiandrogens affect androgen-dependent body functions and are used for various medical conditions, with some risks like fetus feminization, but new forms like 17α-propylmesterolone show promise for acne without systemic effects.

Different human traits like skin color and hair type vary between populations due to genetic adaptations to the environment.

A rare genetic disease causes rickets and often hair loss in young children, which can improve with specific treatments.

Direct vasodilators and sympatholytic agents are still useful for certain conditions despite being less common due to side effects and newer drugs.

Men with hormonal imbalances similar to PCOS may have increased risk of metabolic and heart diseases.

More research is needed to understand how testosterone is maintained in adult males.

Significant progress was made in understanding PXE, but effective treatments are still needed.

Dexamethasone mini-pulse therapy is effective for alopecia areata but less effective for those with early onset or hypothyroidism.

COVID-19 patients often have skin issues like chilblain-like lesions and rashes, which can help in early diagnosis and sometimes indicate severe illness.

People with first-time vitiligo have lower levels of a certain brain protein compared to healthy individuals.

Tinea capitis is increasingly common in elderly women and requires accurate diagnosis with fungal cultures for effective treatment.

Pediatric pemphigus is often diagnosed late, but rituximab helps control it long-term.

The convention discussed various skin conditions and treatments, and highlighted the importance of vaccinations for patients on immune-altering medications.

A potential link exists between unexplained hormone deficiency, hair loss, and testicular tumors, suggesting thorough screening is needed.

Statins may help treat PCOS by lowering androgen levels and improving cholesterol.

Corticosteroid pulse therapy is more effective for severe alopecia areata than combination therapy.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

Hair loss in Androgenetic Alopecia is caused by genetics, aging, and lifestyle, leading to hair follicle shrinkage and related health risks.

The document concludes that more research is needed to reduce frequent hospital visits, addiction medicine education improves with specific training, early breast cancer surgery findings are emerging, nipple smears are not very accurate, surgery for older melanoma patients doesn't extend life, a genetic condition in infants can often be treated with one drug, doctors are inconsistent with blood clot medication, a certain gene may protect against cell damage, muscle gene overexpression affects many other genes, and some mitochondrial genes are less active in mice with tumors.

The study concludes that Traction Alopecia is often overlooked in women and children of color, and better recognition and follow-up care are needed.

CBD may improve skin and hair health, but its effective use and safety need more research.

Sons of mothers with polycystic ovary syndrome (PCOS) have a higher risk of obesity and insulin resistance, possibly due to certain genes and factors passed down from their mothers.

Testosterone is key for male sexual function, and treating hormone imbalances can improve sexual issues.

Stem cells in hair follicles are diverse and change throughout the hair cycle.

RNA delivery is best for in-body use, while RNP delivery is good for outside-body use. Both methods are expected to greatly impact future treatments.

The 2023 guideline advises a detailed approach for PCOS, focusing on early detection, lifestyle and medical treatments, and managing health risks.